Opportunity ID: 356760

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-25-078
Funding Opportunity Title: NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 18, 2024
Last Updated Date: Oct 18, 2024
Original Closing Date for Applications: Jan 07, 2026
Current Closing Date for Applications: Jan 07, 2026
Archive Date: Feb 12, 2026
Estimated Total Program Funding:
Award Ceiling: $50,000
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Small businesses
For profit organizations other than small businesses
County governments
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
Independent school districts
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This notice of funding opportunity (NOFO) supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-25-078.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 356760 Full Announcement-PAR-25-078 -> PAR-25-078-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-I Use for due dates on or after January 25, 2025 PKG00288417 Jan 24, 2025 Jan 07, 2026 View

Package 1

Mandatory forms

356760 RR_SF424_5_0-5.0.pdf

356760 PHS398_CoverPageSupplement_5_0-5.0.pdf

356760 RR_OtherProjectInfo_1_4-1.4.pdf

356760 PerformanceSite_4_0-4.0.pdf

356760 RR_KeyPersonExpanded_4_0-4.0.pdf

356760 PHS398_ResearchPlan_5_0-5.0.pdf

356760 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

356760 RR_Budget_3_0-3.0.pdf

356760 RR_SubawardBudget30_3_0-3.0.pdf

356760 PHS398_ModularBudget_1_2-1.2.pdf

356760 PHS_AssignmentRequestForm_4_0-4.0.pdf

2025-07-13T10:16:59-05:00

Share This Post, Choose Your Platform!

About the Author: